Xizang Haisco Pharmaceutical Group Co Ltd (002653) — Capital Reinvestment Ratio
Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a Capital Reinvestment Ratio of 1.83x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥39.68 Million) in capital expenditures (CN¥72.46 Million). Check Xizang Haisco Pharmaceutical Group Co Lt (002653) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Xizang Haisco Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (2008–2025)
This chart tracks Xizang Haisco Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 18 annual periods. For the full cash flow conversion analysis, see Xizang Haisco Pharmaceutical Group Co Lt operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)
Year-by-year Capital Reinvestment Ratio for Xizang Haisco Pharmaceutical Group Co Ltd from 2008 to 2025. See Xizang Haisco Pharmaceutical Group Co Lt (002653) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.42x | CN¥786.00 Million | CN¥331.98 Million | ▼ -57.6% |
| 2024 | 1.00x | CN¥442.05 Million | CN¥440.65 Million | ▲ +14.6% |
| 2023 | 0.87x | CN¥449.58 Million | CN¥391.01 Million | ▼ -88.3% |
| 2022 | 7.41x | CN¥94.55 Million | CN¥700.17 Million | ▼ -62.3% |
| 2021 | 19.63x | CN¥35.80 Million | CN¥702.94 Million | ▲ +572.9% |
| 2020 | 2.92x | CN¥206.21 Million | CN¥601.72 Million | ▲ +282.7% |
| 2019 | 0.76x | CN¥764.26 Million | CN¥582.68 Million | ▲ +2.4% |
| 2018 | 0.74x | CN¥472.61 Million | CN¥351.98 Million | ▼ -25.8% |
| 2017 | 1.00x | CN¥391.81 Million | CN¥393.26 Million | ▲ +97.2% |
| 2016 | 0.51x | CN¥409.20 Million | CN¥208.24 Million | ▼ -20.5% |
| 2015 | 0.64x | CN¥443.03 Million | CN¥283.68 Million | ▲ +37.0% |
| 2014 | 0.47x | CN¥502.57 Million | CN¥234.86 Million | ▲ +62.0% |
| 2013 | 0.29x | CN¥568.41 Million | CN¥163.98 Million | ▲ +7.0% |
| 2012 | 0.27x | CN¥464.75 Million | CN¥125.30 Million | ▼ -40.3% |
| 2011 | 0.45x | CN¥260.79 Million | CN¥117.72 Million | ▲ +104.9% |
| 2010 | 0.22x | CN¥367.38 Million | CN¥80.95 Million | ▲ +237.9% |
| 2009 | 0.07x | CN¥368.21 Million | CN¥24.01 Million | ▼ -83.5% |
| 2008 | 0.40x | CN¥94.45 Million | CN¥37.38 Million | — |